Search for: "Astra Zeneca Pharmaceuticals" Results 21 - 36 of 36
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 May 2010, 1:10 pm by FDABlog HPM
  HCP reports have already spurred a number of letters; one of the more recent is an Untitled Letter to Astra Zeneca from December 2008 about misleading sales representative statements that solicited a request for more information about an off-label use for Seroquel. [read post]
28 Apr 2010, 10:40 am
Astra Zeneca, although continuing to deny that it did anything wrong, will nevertheless poney up over a half billion dollars. [read post]
28 Apr 2010, 7:14 am by Mark Zamora
From the DOJ Press Statement:AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Departments of Justice and Health and Human Services’ Health Care Fraud Enforcement Action Team (HEAT) announced today. [read post]
19 Apr 2010, 11:39 am by Phillips & Cohen
It details the activities and successes of NY's MFCU.The report highlights Operation Home Alone, an investigation of corruption in the home care industry; settlements with several pharmaceutical companies, including Eli Lilly, Pfizer, Mylan Pharmaceuticals, Astra Zeneca, and Aventis for off-label marketing, kickbacks, misreporting prices, and other fraud; nursing home fraud investigations; and other types of program fraud. [read post]
17 Feb 2010, 5:10 am
King Pharmaceuticals Inc. et al (Patent Docs) Famvir (Famciclovir) – US: Teva and Novartis settle patent litigation regarding Famciclovir (IP Factor) (SmartBrief) Gardasil, Silgard - Portugal: More on Gardasil and Silgard from Portugal (SPC Blog) Lipitor (Atorvastatin) – Philippines: UniLab can still sell generic version of Pfizer's Lipitor after a Makati court denies latter's petition for preliminary injunction (GenericsWeb) Mucinex (Guaifenesin) – US: W D… [read post]
20 Oct 2009, 1:15 am
The US Attorney’s office in New Hampshire announced yesterday the settlement of a qui tam alleging that four pharmaceutical companies - Mylan Pharmaceuticals, UDL Laboratories, Aztra-Zeneca Pharmaceuticals, and Ortho-McNeill - mischaracterized their prescription drugs to state Medicaid programs. [read post]
6 Oct 2009, 4:00 am
AstraZeneca was formed through a 1999 merger between Britain's Zeneca Group PLC and Sweden's Astra AB, the parent of Astra USA.Corporate boards face mounting pressure to crack down on executives who breach their fiduciary duty, said Thomas C. [read post]
3 Aug 2009, 10:35 pm
Sun Pharmaceuticals has settled with Medimmune (Astra Zeneca ) concerning the (Hatch-Waxman) patent dispute over Ethyol (amifostine), a drug which is used to reduce toxicities associated with chemotherapy and radiation in head and neck cancers. [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
28 Nov 2008, 12:49 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com]   Highlights this week included: EPO Enlarged Board of Appeal turns down Wisconsin Alumni Research Foundation (WARF) stem cell application (IAM) (IPKat) (EPO) European Commission releases… [read post]
15 Apr 2008, 8:09 pm
Conference highlights include: Article 81: licensing, distribution arrangements, settlement agreements Article 82: the Astra/Zeneca case and its consequences for the pharmaceutical industry, plus lessons to be learned from Microsoft Restructuring distribution systems in Europe Analysis of patent actions in Europe European legislation initiatives: EPC 2000, EPLA and the Enforcement Directive Implementation of the New Medicines Legislation and adoption of the New Penalties… [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
5 Nov 2006, 8:29 pm
Mylan Toprol XL--Astra Zeneca v. [read post]
29 Oct 2006, 7:43 pm
Previously, Astra sued KV, Andrx Pharmaceuticals, and Eon Laboratories based on ANDA filings for Toprol XL generics. [read post]